Selection procedure reference: EMA/TR/11125
Duration: 10 months
Deadline for applications: 30 September 2025 23:59 CET
The European Medicines Agency (EMA) is a decentralised agency of the European Union (EU), located in Amsterdam. It began operating in 1995. It is responsible for the scientific evaluation, supervision and safety monitoring of medicines in the EU.
This traineeship opportunity is now open for applications until 30 September 2025 23:59 CET, with an intake on 1 March 2026.
About the traineeship programme: The Agency is looking for motivated, qualified recent graduates or students on an Erasmus+ or other programme or PhD students or Master’s students (who posses a previous degree), who are interested in gaining experience and contribute to the Agency’s work for every patient in Europe. The purpose of a traineeship at the Agency is to perform tasks that are predominantly in the interest of the trainee’s training and principally serve to increase the trainee’s knowledge and to gain relevant experience.
Placement description: We are looking for a trainee in the Scientific Evidence Generation Department within Human Medicines Division.
Specific objectives and projects
This traineeship will provide the successful candidate with an opportunity to delve into the marketing authorisation dossiers of products for the treatment of obesity, diabetes, and cardiovascular disorders and answer some important questions for us.
Obesity affects a significant portion of the general population and is a major risk factor for developing cardiovascular and endocrine diseases, such as type 2 diabetes, coronary heart disease, and stroke. Given this, medicinal products designed for the prevention and treatment of these conditions must be studied in populations affected by obesity or modelling should support dosing regimens in people living with obesity. Thus, alternative modelling approaches should be explored to understand how obesity influences the pharmacokinetics and pharmacodynamics of these treatments.
The altered body composition, changes in physiology, the presence of steatosis, and the chronic inflammation associated with obesity can significantly affect how a drug is absorbed, distributed, metabolized, and excreted in individuals with obesity compared to those without it.
The main goal of this project is to evaluate the existing data that can inform the use of medicinal products in people living with obesity at the time of marketing authorization. We will focus primarily on products targeting diseases where people living with obesity make up a large portion of the patient population. The trainee will contribute to the design, data collection, and analysis of research examining the evidence base for these medicinal products in individuals living with obesity. Through this project, the trainee will also be involved in the regulatory and scientific activities of the Translational Sciences Office.
Learning outcomes
Through this traineeship, the trainee will :
Eligibility criteria
To be eligible for consideration for this placement, you are required to:
For criteria 1 and 2, you will be required to provide proof in the application form and at the interview stage. Failing to present these documents may result in the disqualification from the procedure.
Additional skills
In addition to the eligibility criteria, you will have:
Conditions of traineeship: The traineeship is offered for 10 months (1 March 2026 – 31 December 2026) and takes place at the Agency’s premises in Amsterdam with possibility for teleworking up to 40% of working time from The Netherlands and occasional teleworking from outside The Netherlands. Traineeships are offered for either full-time or part-time (80% or 50%) if combined with university studies.
The Agency pays a monthly stipend of €1,963.93 for a full-time traineeship (reduced accordingly for 80% or 50%) and a travel contribution upon joining the Agency.
Each trainee will have a mentor at the Agency who will guide the trainee through the programme.
The conditions of employment are stated in the Executive Decision on rules governing the traineeship programme at the EMA available at the website.
Expected selection timelines
Deadline for Applications: 30 September 2025 23:59 CET
“While we try our best to keep our information updated, the closing date of the actual job source may be changed by the recruiter without prior notice. With this, please make sure to check the official job link when submitting your application. Thank you.”
